<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-12-01" modified="2018-01-31" version="194">
<accession>Q13191</accession>
<accession>A8K9S7</accession>
<accession>B7WNM4</accession>
<accession>Q13192</accession>
<accession>Q13193</accession>
<accession>Q3LIC0</accession>
<accession>Q63Z43</accession>
<accession>Q8IVC5</accession>
<name>CBLB_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 ubiquitin-protein ligase CBL-B</fullName>
<ecNumber evidence="18 25">2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Casitas B-lineage lymphoma proto-oncogene b</fullName>
</alternativeName>
<alternativeName>
<fullName>RING finger protein 56</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="29">RING-type E3 ubiquitin transferase CBL-B</fullName>
</alternativeName>
<alternativeName>
<fullName>SH3-binding protein CBL-B</fullName>
</alternativeName>
<alternativeName>
<fullName>Signal transduction protein CBL-B</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CBLB</name>
<name type="synonym">RNF56</name>
<name type="ORF">Nbla00127</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Oncogene" volume="10" first="2367" last="2377">
<title>Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene.</title>
<authorList>
<person name="Keane M.M."/>
<person name="Rivero-Lezcano O.M."/>
<person name="Mitchell J.A."/>
<person name="Robbins K.C."/>
<person name="Lipkowitz S."/>
</authorList>
<dbReference type="PubMed" id="7784085"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG; TRUNCATED 1 AND TRUNCATED 2)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Oncogene" volume="15" first="2511" last="2520">
<title>Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation.</title>
<authorList>
<person name="Bustelo X.R."/>
<person name="Crespo P."/>
<person name="Lopez-Barahona M."/>
<person name="Gutkind J.S."/>
<person name="Barbacid M."/>
</authorList>
<dbReference type="PubMed" id="9399639"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201430"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH VAV1</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-12" db="EMBL/GenBank/DDBJ databases">
<title>Cbl-b in Taiwan population.</title>
<authorList>
<person name="Shen C.-R."/>
<person name="Chen Y.-J."/>
<person name="Pai L.-M."/>
<person name="Liu C.-L."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG)</scope>
<source>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1194" last="1198">
<title>The DNA sequence, annotation and analysis of human chromosome 3.</title>
<authorList>
<person name="Muzny D.M."/>
<person name="Scherer S.E."/>
<person name="Kaul R."/>
<person name="Wang J."/>
<person name="Yu J."/>
<person name="Sudbrak R."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Wei S."/>
<person name="Wheeler D.A."/>
<person name="Wright M.W."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clendenning J."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Chen R."/>
<person name="Chen Z."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Dong W."/>
<person name="Draper H."/>
<person name="Ernst S."/>
<person name="Fu G."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Garcia D.K."/>
<person name="Gillett W."/>
<person name="Gu J."/>
<person name="Hao B."/>
<person name="Haugen E."/>
<person name="Havlak P."/>
<person name="He X."/>
<person name="Hennig S."/>
<person name="Hu S."/>
<person name="Huang W."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Kube M."/>
<person name="Levy R."/>
<person name="Li Z."/>
<person name="Liu B."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Palmeiri A."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Phelps K.A."/>
<person name="Plopper F.J."/>
<person name="Qiang B."/>
<person name="Raymond C."/>
<person name="Rodriguez R."/>
<person name="Saenphimmachak C."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Shen Y."/>
<person name="Subramanian S."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang J."/>
<person name="Wang J."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Wong G.K.-S."/>
<person name="Yao Z."/>
<person name="Zhang J."/>
<person name="Zhang X."/>
<person name="Zhao G."/>
<person name="Zhou J."/>
<person name="Zhou Y."/>
<person name="Nelson D."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Naylor S.L."/>
<person name="Yang H."/>
<person name="Olson M."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16641997"/>
<dbReference type="DOI" id="10.1038/nature04728"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG)</scope>
<scope>VARIANT LYS-584</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Cancer Lett." volume="197" first="63" last="68">
<title>Neuroblastoma oligo-capping cDNA project: toward the understanding of the genesis and biology of neuroblastoma.</title>
<authorList>
<person name="Ohira M."/>
<person name="Morohashi A."/>
<person name="Nakamura Y."/>
<person name="Isogai E."/>
<person name="Furuya K."/>
<person name="Hamano S."/>
<person name="Machida T."/>
<person name="Aoyama M."/>
<person name="Fukumura M."/>
<person name="Miyazaki K."/>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Hirato J."/>
<person name="Nakagawara A."/>
</authorList>
<dbReference type="PubMed" id="12880961"/>
<dbReference type="DOI" id="10.1016/S0304-3835(03)00085-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 543-982 (ISOFORM LONG)</scope>
<source>
<tissue>Neuroblastoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 857-982 (ISOFORM LONG)</scope>
<source>
<tissue>Small intestine</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="1147" last="1156">
<title>Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation.</title>
<authorList>
<person name="Elly C."/>
<person name="Witte S."/>
<person name="Zhang Z."/>
<person name="Rosnet O."/>
<person name="Lipkowitz S."/>
<person name="Altman A."/>
<person name="Liu Y.-C."/>
</authorList>
<dbReference type="PubMed" id="10022120"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202411"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF GLY-298; TYR-665 AND TYR-709</scope>
<scope>INTERACTION WITH GRB2 AND CRKL</scope>
<scope>PHOSPHORYLATION AT TYR-665 AND TYR-709</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="1855" last="1866">
<title>cbl-b inhibits epidermal growth factor receptor signaling.</title>
<authorList>
<person name="Ettenberg S.A."/>
<person name="Keane M.M."/>
<person name="Nau M.M."/>
<person name="Frankel M."/>
<person name="Wang L.-M."/>
<person name="Pierce J.H."/>
<person name="Lipkowitz S."/>
</authorList>
<dbReference type="PubMed" id="10086340"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202499"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH GRB2 AND PIK3R1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="4872" last="4878">
<title>Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells.</title>
<authorList>
<person name="Fang D."/>
<person name="Wang H.-Y."/>
<person name="Fang N."/>
<person name="Altman Y."/>
<person name="Elly C."/>
<person name="Liu Y.-C."/>
</authorList>
<dbReference type="PubMed" id="11087752"/>
<dbReference type="DOI" id="10.1074/jbc.M008901200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PIK3R1</scope>
<scope>MUTAGENESIS OF GLY-298 AND CYS-373</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="27677" last="27684">
<title>Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex.</title>
<authorList>
<person name="Ettenberg S.A."/>
<person name="Magnifico A."/>
<person name="Cuello M."/>
<person name="Nau M.M."/>
<person name="Rubinstein Y.R."/>
<person name="Yarden Y."/>
<person name="Weissman A.M."/>
<person name="Lipkowitz S."/>
</authorList>
<dbReference type="PubMed" id="11375397"/>
<dbReference type="DOI" id="10.1074/jbc.M102641200"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF CYS-373</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2001" name="Nat. Immunol." volume="2" first="870" last="875">
<title>Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells.</title>
<authorList>
<person name="Fang D."/>
<person name="Liu Y.-C."/>
</authorList>
<dbReference type="PubMed" id="11526404"/>
<dbReference type="DOI" id="10.1038/ni0901-870"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="39666" last="39672">
<title>CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases.</title>
<authorList>
<person name="Szymkiewicz I."/>
<person name="Kowanetz K."/>
<person name="Soubeyran P."/>
<person name="Dinarina A."/>
<person name="Lipkowitz S."/>
<person name="Dikic I."/>
</authorList>
<dbReference type="PubMed" id="12177062"/>
<dbReference type="DOI" id="10.1074/jbc.M205535200"/>
</citation>
<scope>INTERACTION WITH SH3KBP1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="1645" last="1655">
<title>Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation.</title>
<authorList>
<person name="Kim M."/>
<person name="Tezuka T."/>
<person name="Tanaka K."/>
<person name="Yamamoto T."/>
</authorList>
<dbReference type="PubMed" id="14661060"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207298"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="7104" last="7115">
<title>Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b.</title>
<authorList>
<person name="Davies G.C."/>
<person name="Ettenberg S.A."/>
<person name="Coats A.O."/>
<person name="Mussante M."/>
<person name="Ravichandran S."/>
<person name="Collins J."/>
<person name="Nau M.M."/>
<person name="Lipkowitz S."/>
</authorList>
<dbReference type="PubMed" id="15273720"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207952"/>
</citation>
<scope>INTERACTION WITH UBIQUITINATED PROTEINS</scope>
<scope>MUTAGENESIS OF 943-GLY-TYR-944 AND LEU-967</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-521; SER-525 AND SER-529</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA30" last="RA30">
<title>PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation.</title>
<authorList>
<person name="Gruber T."/>
<person name="Hermann-Kleiter N."/>
<person name="Hinterleitner R."/>
<person name="Fresser F."/>
<person name="Schneider R."/>
<person name="Gastl G."/>
<person name="Penninger J.M."/>
<person name="Baier G."/>
</authorList>
<dbReference type="PubMed" id="19549985"/>
<dbReference type="DOI" id="10.1126/scisignal.2000046"/>
</citation>
<scope>PHOSPHORYLATION AT SER-282</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="23687" last="23698">
<title>The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme.</title>
<authorList>
<person name="Ryan P.E."/>
<person name="Sivadasan-Nair N."/>
<person name="Nau M.M."/>
<person name="Nicholas S."/>
<person name="Lipkowitz S."/>
</authorList>
<dbReference type="PubMed" id="20525694"/>
<dbReference type="DOI" id="10.1074/jbc.M109.091157"/>
</citation>
<scope>FUNCTION AS E3 UBIQUITIN-PROTEIN LIGASE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PHOSPHORYLATION AT TYR-363</scope>
<scope>MUTAGENESIS OF TYR-363</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="Nat. Struct. Mol. Biol." volume="12" first="972" last="979">
<title>Cbl promotes clustering of endocytic adaptor proteins.</title>
<authorList>
<person name="Jozic D."/>
<person name="Cardenes N."/>
<person name="Deribe Y.L."/>
<person name="Moncalian G."/>
<person name="Hoeller D."/>
<person name="Groemping Y."/>
<person name="Dikic I."/>
<person name="Rittinger K."/>
<person name="Bravo J."/>
</authorList>
<dbReference type="PubMed" id="16228008"/>
<dbReference type="DOI" id="10.1038/nsmb1000"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 899-914 IN COMPLEXES WITH SH3KBP1 AND ARHGEF7</scope>
<scope>MUTAGENESIS OF ARG-904 AND ARG-911</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="38845" last="38853">
<title>Atypical polyproline recognition by the CMS N-terminal Src homology 3 domain.</title>
<authorList>
<person name="Moncalian G."/>
<person name="Cardenes N."/>
<person name="Deribe Y.L."/>
<person name="Spinola-Amilibia M."/>
<person name="Dikic I."/>
<person name="Bravo J."/>
</authorList>
<dbReference type="PubMed" id="17020880"/>
<dbReference type="DOI" id="10.1074/jbc.M606411200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 902-912 IN COMPLEX WITH CD2AP</scope>
<scope>MUTAGENESIS OF ARG-904; LYS-907 AND ARG-911</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="Mol. Cell" volume="27" first="474" last="485">
<title>Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b.</title>
<authorList>
<person name="Peschard P."/>
<person name="Kozlov G."/>
<person name="Lin T."/>
<person name="Mirza I.A."/>
<person name="Berghuis A.M."/>
<person name="Lipkowitz S."/>
<person name="Park M."/>
<person name="Gehring K."/>
</authorList>
<dbReference type="PubMed" id="17679095"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.06.023"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.56 ANGSTROMS) OF 924-973 IN COMPLEX WITH UBIQUITIN</scope>
<scope>STRUCTURE BY NMR OF 924-973</scope>
<scope>TYROSINE PHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF ALA-937; MET-940; PHE-946 AND ILE-966</scope>
</reference>
<reference key="25">
<citation type="submission" date="2007-05" db="PDB data bank">
<title>Solution structure of RSGI RUH-065, a UBA domain from human cDNA.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 931-970</scope>
</reference>
<reference key="26">
<citation type="submission" date="2010-10" db="PDB data bank">
<title>Crystal structure of Cbl-b TKB domain in complex with EGFR pY1069 peptide.</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.27 ANGSTROMS) OF 38-344 IN COMPLEX WITH PHOSPHO-EGFR PEPTIDE</scope>
<scope>INTERACTION WITH EGFR</scope>
<scope>HETERODIMER</scope>
</reference>
<comment type="function">
<text evidence="12 13 14 16 18 25">E3 ubiquitin-protein ligase which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and transfers it to substrates, generally promoting their degradation by the proteasome. Negatively regulates TCR (T-cell receptor), BCR (B-cell receptor) and FCER1 (high affinity immunoglobulin epsilon receptor) signal transduction pathways. In naive T-cells, inhibits VAV1 activation upon TCR engagement and imposes a requirement for CD28 costimulation for proliferation and IL-2 production. Also acts by promoting PIK3R1/p85 ubiquitination, which impairs its recruitment to the TCR and subsequent activation. In activated T-cells, inhibits PLCG1 activation and calcium mobilization upon restimulation and promotes anergy. In B-cells, acts by ubiquitinating SYK and promoting its proteasomal degradation. Slightly promotes SRC ubiquitination. May be involved in EGFR ubiquitination and internalization. May be functionally coupled with the E2 ubiquitin-protein ligase UB2D3.</text>
</comment>
<comment type="catalytic activity">
<text evidence="18 25">S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="12 13 14 17 19 21 22 23 26 27">Interacts with SH3 domain-containing proteins LCK, CRK and SORBS1. Interacts with LCP2 and ZAP70. May interact with CBL. Interacts with SH3 domain-containing proteins VAV1, FYN, FGR, PLCG1, GRB2, CRKL, PIK3R1 and SH3KBP1/CIN85. Identified in heterotrimeric complexes with SH3KBP1/CIN85, CD2AP and ARHGEF7, where one CBLB peptide binds two copies of the other protein. Interacts with poly-ubiquitinated proteins. Dimerization is required for the binding of poly-ubiquitin, but not for the binding of mono-ubiquitin. Interacts with EGFR (phosphorylated).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15555129"/>
<interactant intactId="EBI-3649585">
<id>O55043</id>
<label>Arhgef7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-744027"/>
<interactant intactId="EBI-346622">
<id>Q9ULH1</id>
<label>ASAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15555129"/>
<interactant intactId="EBI-7006141">
<id>Q9BXL7</id>
<label>CARD11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-744027"/>
<interactant intactId="EBI-298152">
<id>Q9Y5K6</id>
<label>CD2AP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-744027"/>
<interactant intactId="EBI-886">
<id>P46108</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-744027"/>
<interactant intactId="EBI-910">
<id>P46109</id>
<label>CRKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-744027"/>
<interactant intactId="EBI-10691738">
<id>P06241-3</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-744027"/>
<interactant intactId="EBI-374781">
<id>O76003</id>
<label>GLRX3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-744027"/>
<interactant intactId="EBI-739467">
<id>Q9H8Y8</id>
<label>GORASP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-744027"/>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-744027"/>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-744027"/>
<interactant intactId="EBI-713635">
<id>O43639</id>
<label>NCK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-744027"/>
<interactant intactId="EBI-78458">
<id>P55345</id>
<label>PRMT2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-744027"/>
<interactant intactId="EBI-346595">
<id>Q96B97</id>
<label>SH3KBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>21</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15555129"/>
<interactant intactId="EBI-7585212">
<id>Q96B97-1</id>
<label>SH3KBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-744027"/>
<interactant intactId="EBI-1380492">
<id>Q8TF42</id>
<label>UBASH3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15555129"/>
<interactant intactId="EBI-347677">
<id>P62837</id>
<label>UBE2D2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="17">Cytoplasm</location>
</subcellularLocation>
<text>Upon EGF stimulation, associates with endocytic vesicles.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q13191-1</id>
<name>Long</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q13191-2</id>
<name>Truncated 1</name>
<sequence type="described" ref="VSP_005729"/>
</isoform>
<isoform>
<id>Q13191-3</id>
<name>Truncated 2</name>
<sequence type="described" ref="VSP_005730 VSP_005731"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="12 26">Expressed in placenta, heart, lung, kidney, spleen, ovary and testis, as well as fetal brain and liver and hematopoietic cell lines, but not in adult brain, liver, pancreas, salivary gland, or skeletal muscle. Present in lymphocytes (at protein level).</text>
</comment>
<comment type="domain">
<text>The N-terminus is composed of the phosphotyrosine binding (PTB) domain, a short linker region and the RING-type zinc finger. The PTB domain, which is also called TKB (tyrosine kinase binding) domain, is composed of three different subdomains: a four-helix bundle (4H), a calcium-binding EF hand and a divergent SH2 domain.</text>
</comment>
<comment type="domain">
<text>The RING-type zinc finger domain mediates binding to an E2 ubiquitin-conjugating enzyme.</text>
</comment>
<comment type="domain">
<text>The UBA domain interacts with poly-ubiquitinated proteins.</text>
</comment>
<comment type="PTM">
<text evidence="12 13 24 25">Phosphorylated on tyrosine and serine residues upon TCR or BCR activation, and upon various types of cell stimulation.</text>
</comment>
<comment type="PTM">
<text evidence="15">Auto-ubiquitinated upon EGF-mediated cell activation or upon T-cell costimulation by CD28; which promotes proteasomal degradation.</text>
</comment>
<comment type="miscellaneous">
<text evidence="6">This protein has one functional calcium-binding site.</text>
</comment>
<comment type="sequence caution" evidence="29">
<conflict type="erroneous termination">
<sequence resource="EMBL-CDS" id="BAE45748" version="1"/>
</conflict>
<location>
<position position="904"/>
</location>
<text>Translated as Arg.</text>
</comment>
<comment type="sequence caution" evidence="29">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="CAH56175" version="1"/>
</conflict>
<text>Probable cloning artifact.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CBLbID193.html"/>
</comment>
<dbReference type="EC" id="2.3.2.27" evidence="18 25"/>
<dbReference type="EMBL" id="U26710">
<property type="protein sequence ID" value="AAB09291.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U26711">
<property type="protein sequence ID" value="AAB09292.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U26712">
<property type="protein sequence ID" value="AAB09293.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ349203">
<property type="protein sequence ID" value="ABC86700.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292792">
<property type="protein sequence ID" value="BAF85481.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC016138">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471052">
<property type="protein sequence ID" value="EAW79752.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471052">
<property type="protein sequence ID" value="EAW79753.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471052">
<property type="protein sequence ID" value="EAW79754.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC032851">
<property type="protein sequence ID" value="AAH32851.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB075490">
<property type="protein sequence ID" value="BAE45748.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX537484">
<property type="protein sequence ID" value="CAH56175.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2948.1">
<molecule id="Q13191-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001308717.1">
<molecule id="Q13191-1"/>
<property type="nucleotide sequence ID" value="NM_001321788.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_733762.2">
<molecule id="Q13191-1"/>
<property type="nucleotide sequence ID" value="NM_170662.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011511559.1">
<molecule id="Q13191-1"/>
<property type="nucleotide sequence ID" value="XM_011513257.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.430589"/>
<dbReference type="PDB" id="2AK5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="D=904-911"/>
</dbReference>
<dbReference type="PDB" id="2BZ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="C=902-912"/>
</dbReference>
<dbReference type="PDB" id="2DO6">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=931-970"/>
</dbReference>
<dbReference type="PDB" id="2J6F">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="C=902-912"/>
</dbReference>
<dbReference type="PDB" id="2JNH">
<property type="method" value="NMR"/>
<property type="chains" value="A=926-971"/>
</dbReference>
<dbReference type="PDB" id="2LDR">
<property type="method" value="NMR"/>
<property type="chains" value="A=351-426"/>
</dbReference>
<dbReference type="PDB" id="2OOA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.56"/>
<property type="chains" value="A/B=924-973"/>
</dbReference>
<dbReference type="PDB" id="2OOB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=924-973"/>
</dbReference>
<dbReference type="PDB" id="3PFV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.27"/>
<property type="chains" value="A/B=38-344"/>
</dbReference>
<dbReference type="PDB" id="3VGO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B/C=39-426"/>
</dbReference>
<dbReference type="PDB" id="3ZNI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.21"/>
<property type="chains" value="A/E/I/M=36-427"/>
</dbReference>
<dbReference type="PDBsum" id="2AK5"/>
<dbReference type="PDBsum" id="2BZ8"/>
<dbReference type="PDBsum" id="2DO6"/>
<dbReference type="PDBsum" id="2J6F"/>
<dbReference type="PDBsum" id="2JNH"/>
<dbReference type="PDBsum" id="2LDR"/>
<dbReference type="PDBsum" id="2OOA"/>
<dbReference type="PDBsum" id="2OOB"/>
<dbReference type="PDBsum" id="3PFV"/>
<dbReference type="PDBsum" id="3VGO"/>
<dbReference type="PDBsum" id="3ZNI"/>
<dbReference type="ProteinModelPortal" id="Q13191"/>
<dbReference type="SMR" id="Q13191"/>
<dbReference type="BioGrid" id="107316">
<property type="interactions" value="59"/>
</dbReference>
<dbReference type="CORUM" id="Q13191"/>
<dbReference type="DIP" id="DIP-33091N"/>
<dbReference type="IntAct" id="Q13191">
<property type="interactions" value="42"/>
</dbReference>
<dbReference type="MINT" id="MINT-256380"/>
<dbReference type="STRING" id="9606.ENSP00000264122"/>
<dbReference type="iPTMnet" id="Q13191"/>
<dbReference type="PhosphoSitePlus" id="Q13191"/>
<dbReference type="BioMuta" id="CBLB"/>
<dbReference type="DMDM" id="88911265"/>
<dbReference type="EPD" id="Q13191"/>
<dbReference type="MaxQB" id="Q13191"/>
<dbReference type="PaxDb" id="Q13191"/>
<dbReference type="PeptideAtlas" id="Q13191"/>
<dbReference type="PRIDE" id="Q13191"/>
<dbReference type="DNASU" id="868"/>
<dbReference type="Ensembl" id="ENST00000264122">
<molecule id="Q13191-1"/>
<property type="protein sequence ID" value="ENSP00000264122"/>
<property type="gene ID" value="ENSG00000114423"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000403724">
<molecule id="Q13191-3"/>
<property type="protein sequence ID" value="ENSP00000384816"/>
<property type="gene ID" value="ENSG00000114423"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000405772">
<molecule id="Q13191-2"/>
<property type="protein sequence ID" value="ENSP00000384938"/>
<property type="gene ID" value="ENSG00000114423"/>
</dbReference>
<dbReference type="GeneID" id="868"/>
<dbReference type="KEGG" id="hsa:868"/>
<dbReference type="UCSC" id="uc003dwc.4">
<molecule id="Q13191-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="868"/>
<dbReference type="DisGeNET" id="868"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000114423.18"/>
<dbReference type="GeneCards" id="CBLB"/>
<dbReference type="H-InvDB" id="HIX0003518"/>
<dbReference type="HGNC" id="HGNC:1542">
<property type="gene designation" value="CBLB"/>
</dbReference>
<dbReference type="HPA" id="HPA018327"/>
<dbReference type="HPA" id="HPA019880"/>
<dbReference type="MIM" id="604491">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q13191"/>
<dbReference type="OpenTargets" id="ENSG00000114423"/>
<dbReference type="PharmGKB" id="PA26116"/>
<dbReference type="eggNOG" id="KOG1785">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410YDNH">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000011617"/>
<dbReference type="HOVERGEN" id="HBG005255"/>
<dbReference type="InParanoid" id="Q13191"/>
<dbReference type="KO" id="K04707"/>
<dbReference type="OMA" id="CCSIIDP"/>
<dbReference type="OrthoDB" id="EOG091G0GPE"/>
<dbReference type="PhylomeDB" id="Q13191"/>
<dbReference type="TreeFam" id="TF314210"/>
<dbReference type="BRENDA" id="6.3.2.19">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983168">
<property type="pathway name" value="Antigen processing: Ubiquitination &amp; Proteasome degradation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983695">
<property type="pathway name" value="Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"/>
</dbReference>
<dbReference type="SignaLink" id="Q13191"/>
<dbReference type="SIGNOR" id="Q13191"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="ChiTaRS" id="CBLB">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q13191"/>
<dbReference type="GeneWiki" id="CBLB_(gene)"/>
<dbReference type="GenomeRNAi" id="868"/>
<dbReference type="PRO" id="PR:Q13191"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000114423"/>
<dbReference type="CleanEx" id="HS_CBLB"/>
<dbReference type="ExpressionAtlas" id="Q13191">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q13191">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0001784">
<property type="term" value="F:phosphotyrosine residue binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0030971">
<property type="term" value="F:receptor tyrosine kinase binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0017124">
<property type="term" value="F:SH3 domain binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004871">
<property type="term" value="F:signal transducer activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007173">
<property type="term" value="P:epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007175">
<property type="term" value="P:negative regulation of epidermal growth factor-activated receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006607">
<property type="term" value="P:NLS-bearing protein import into nucleus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006508">
<property type="term" value="P:proteolysis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="CDD" id="cd09920">
<property type="entry name" value="SH2_Cbl-b_TKB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.930.20">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR024162">
<property type="entry name" value="Adaptor_Cbl"/>
</dbReference>
<dbReference type="InterPro" id="IPR014741">
<property type="entry name" value="Adaptor_Cbl_EF_hand-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR036537">
<property type="entry name" value="Adaptor_Cbl_N_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR003153">
<property type="entry name" value="Adaptor_Cbl_N_hlx"/>
</dbReference>
<dbReference type="InterPro" id="IPR014742">
<property type="entry name" value="Adaptor_Cbl_SH2-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR024159">
<property type="entry name" value="Cbl_PTB"/>
</dbReference>
<dbReference type="InterPro" id="IPR011992">
<property type="entry name" value="EF-hand-dom_pair"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR015940">
<property type="entry name" value="UBA"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR017907">
<property type="entry name" value="Znf_RING_CS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR23007">
<property type="entry name" value="PTHR23007"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02262">
<property type="entry name" value="Cbl_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02761">
<property type="entry name" value="Cbl_N2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02762">
<property type="entry name" value="Cbl_N3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00184">
<property type="entry name" value="RING"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00165">
<property type="entry name" value="UBA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47473">
<property type="entry name" value="SSF47473"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47668">
<property type="entry name" value="SSF47668"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51506">
<property type="entry name" value="CBL_PTB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50030">
<property type="entry name" value="UBA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00518">
<property type="entry name" value="ZF_RING_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="E3 ubiquitin-protein ligase CBL-B" id="PRO_0000055860">
<location>
<begin position="1"/>
<end position="982"/>
</location>
</feature>
<feature type="domain" description="Cbl-PTB" evidence="11">
<location>
<begin position="35"/>
<end position="343"/>
</location>
</feature>
<feature type="domain" description="UBA" evidence="10">
<location>
<begin position="931"/>
<end position="970"/>
</location>
</feature>
<feature type="calcium-binding region" evidence="11">
<location>
<begin position="219"/>
<end position="232"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="9">
<location>
<begin position="373"/>
<end position="412"/>
</location>
</feature>
<feature type="region of interest" description="4H">
<location>
<begin position="35"/>
<end position="167"/>
</location>
</feature>
<feature type="region of interest" description="EF-hand-like">
<location>
<begin position="168"/>
<end position="240"/>
</location>
</feature>
<feature type="region of interest" description="SH2-like">
<location>
<begin position="241"/>
<end position="343"/>
</location>
</feature>
<feature type="region of interest" description="Linker">
<location>
<begin position="344"/>
<end position="372"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with VAV1" evidence="26">
<location>
<begin position="543"/>
<end position="568"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SH3KBP1" evidence="17">
<location>
<begin position="891"/>
<end position="927"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="477"/>
<end position="925"/>
</location>
</feature>
<feature type="binding site" description="Phosphotyrosine" evidence="6">
<location>
<position position="286"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC/PRKCQ" evidence="24">
<location>
<position position="282"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="30">
<location>
<position position="363"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="476"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="480"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="484"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="521"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="525"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="529"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="634"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="12">
<location>
<position position="665"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="12">
<location>
<position position="709"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="7">
<location>
<position position="889"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Truncated 2." id="VSP_005730" evidence="28">
<original>DVFD</original>
<variation>TYRI</variation>
<location>
<begin position="767"/>
<end position="770"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Truncated 2." id="VSP_005731" evidence="28">
<location>
<begin position="771"/>
<end position="982"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Truncated 1." id="VSP_005729" evidence="28">
<location>
<begin position="811"/>
<end position="982"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17853100." id="VAR_025303" evidence="20">
<original>R</original>
<variation>K</variation>
<location>
<position position="584"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35835913." id="VAR_039241">
<original>N</original>
<variation>D</variation>
<location>
<position position="883"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with SYK. No effect on E3 activity." evidence="12 14">
<original>G</original>
<variation>E</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases affinity for E2 ubiquitin-conjugating enzymes." evidence="25">
<original>Y</original>
<variation>E</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes E3 activity but does not affect binding to substrates." evidence="14 15">
<original>C</original>
<variation>A</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly inhibits interaction with CRKL. Abolishes interaction with CRKL; when associated with F-709." evidence="12">
<original>Y</original>
<variation>F</variation>
<location>
<position position="665"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with CRKL. Abolishes interaction with CRKL; when associated with F-665." evidence="12">
<original>Y</original>
<variation>F</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with CD2AP. Reduced interaction with SH3KBP1. Strongly reduced interaction with SH3KBP1; when associated with A-911." evidence="21 22">
<original>R</original>
<variation>A</variation>
<location>
<position position="904"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SH3KBP1. Reduced interaction with CD2AP. Strongly reduced interaction with CD2AP; when associated with A-911." evidence="22">
<original>K</original>
<variation>A</variation>
<location>
<position position="907"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced interaction with CD2AP and with SH3KBP1. Strongly reduced interaction with CD2AP; when associated with A-907. Strongly reduced interaction with SH3KBP1; when associated with A-904." evidence="21 22">
<original>R</original>
<variation>A</variation>
<location>
<position position="911"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ubiquitin binding. Reduced levels of tyrosine phosphorylation." evidence="23">
<original>A</original>
<variation>E</variation>
<location>
<position position="937"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ubiquitin binding. Reduced levels of tyrosine phosphorylation." evidence="23">
<original>M</original>
<variation>A</variation>
<location>
<position position="940"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with ubiquitinated proteins." evidence="19">
<original>GY</original>
<variation>AQ</variation>
<location>
<begin position="943"/>
<end position="944"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ubiquitin binding. Reduced levels of tyrosine phosphorylation." evidence="23">
<original>F</original>
<variation>A</variation>
<location>
<position position="946"/>
</location>
</feature>
<feature type="mutagenesis site" description="Interferes with dimerization. Reduced E3 ubiquitin-protein ligase activity. Reduced levels of tyrosine phosphorylation." evidence="23">
<original>I</original>
<variation>E</variation>
<location>
<position position="966"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with ubiquitinated proteins." evidence="19">
<original>L</original>
<variation>A</variation>
<location>
<position position="967"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB09291/AAB09292/AAB09293." ref="1" evidence="29">
<original>G</original>
<variation>S</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; CAH56175." ref="9" evidence="29">
<original>R</original>
<variation>C</variation>
<location>
<position position="911"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="43"/>
<end position="60"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="63"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="69"/>
<end position="72"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="74"/>
<end position="91"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="95"/>
<end position="102"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="105"/>
<end position="128"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="129"/>
<end position="133"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="138"/>
<end position="160"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="162"/>
<end position="164"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="168"/>
<end position="170"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="176"/>
<end position="186"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="190"/>
<end position="193"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="194"/>
<end position="204"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="210"/>
<end position="220"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="225"/>
<end position="229"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="230"/>
<end position="239"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="243"/>
<end position="245"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="246"/>
<end position="253"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="260"/>
<end position="263"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="266"/>
<end position="273"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="274"/>
<end position="276"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="282"/>
<end position="287"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="289"/>
<end position="291"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="295"/>
<end position="300"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="306"/>
<end position="309"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="312"/>
<end position="314"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="316"/>
<end position="325"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="332"/>
<end position="334"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="342"/>
<end position="344"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="352"/>
<end position="354"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="357"/>
<end position="364"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="365"/>
<end position="367"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="370"/>
<end position="372"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="374"/>
<end position="376"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="377"/>
<end position="380"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="383"/>
<end position="386"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="394"/>
<end position="402"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="409"/>
<end position="411"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="417"/>
<end position="420"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="422"/>
<end position="424"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="933"/>
<end position="941"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="946"/>
<end position="955"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="956"/>
<end position="958"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="960"/>
<end position="970"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2OOA"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3PFV"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3VGO"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3ZNI"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250"/>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q3TTA7"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8K4S7"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00212"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00839"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10022120"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10086340"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11087752"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11375397"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11526404"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12177062"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14661060"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15273720"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16228008"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17020880"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17679095"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19549985"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20525694"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9399639"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source ref="26"/>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7784085"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305"/>
<evidence key="30" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20525694"/>
</source>
</evidence>
<sequence length="982" mass="109450" checksum="B4E307D31B9F0779" modified="2006-02-07" version="2">
MANSMNGRNPGGRGGNPRKGRILGIIDAIQDAVGPPKQAAADRRTVEKTWKLMDKVVRLC
QNPKLQLKNSPPYILDILPDTYQHLRLILSKYDDNQKLAQLSENEYFKIYIDSLMKKSKR
AIRLFKEGKERMYEEQSQDRRNLTKLSLIFSHMLAEIKAIFPNGQFQGDNFRITKADAAE
FWRKFFGDKTIVPWKVFRQCLHEVHQISSGLEAMALKSTIDLTCNDYISVFEFDIFTRLF
QPWGSILRNWNFLAVTHPGYMAFLTYDEVKARLQKYSTKPGSYIFRLSCTRLGQWAIGYV
TGDGNILQTIPHNKPLFQALIDGSREGFYLYPDGRSYNPDLTGLCEPTPHDHIKVTQEQY
ELYCEMGSTFQLCKICAENDKDVKIEPCGHLMCTSCLTAWQESDGQGCPFCRCEIKGTEP
IIVDPFDPRDEGSRCCSIIDPFGMPMLDLDDDDDREESLMMNRLANVRKCTDRQNSPVTS
PGSSPLAQRRKPQPDPLQIPHLSLPPVPPRLDLIQKGIVRSPCGSPTGSPKSSPCMVRKQ
DKPLPAPPPPLRDPPPPPPERPPPIPPDNRLSRHIHHVESVPSRDPPMPLEAWCPRDVFG
TNQLVGCRLLGEGSPKPGITASSNVNGRHSRVGSDPVLMRKHRRHDLPLEGAKVFSNGHL
GSEEYDVPPRLSPPPPVTTLLPSIKCTGPLANSLSEKTRDPVEEDDDEYKIPSSHPVSLN
SQPSHCHNVKPPVRSCDNGHCMLNGTHGPSSEKKSNIPDLSIYLKGDVFDSASDPVPLPP
ARPPTRDNPKHGSSLNRTPSDYDLLIPPLGEDAFDALPPSLPPPPPPARHSLIEHSKPPG
SSSRPSSGQDLFLLPSDPFVDLASGQVPLPPARRLPGENVKTNRTSQDYDQLPSCSDGSQ
APARPPKPRPRRTAPEIHHRKPHGPEAALENVDAKIAKLMGEGYAFEEVKRALEIAQNNV
EVARSILREFAFPPPVSPRLNL
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>